Zortress Tablet
Product Images NDC 0078-0422

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zortress (NDC 0078-0422). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Zortress Structural Formula Of Everolimus Is (1r, 9s, 12s, 15r, 16e, 18r, 19r, 21r, 23s, 24e, 26e, 28e, 30s, 32s, 35r)-1, 18-dihydroxy-12 -{(1r)-2-[(1s,3r,4r)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-1-methylethyl}-19,30-dimethoxy-15, 17, 21, 23, 29, 35-hexamethyl-11, 36-dioxa-4-aza-tricyclo[30.3.1.04,9] Hexatriaconta-16,24,26,28-tetraene-2, 3,10,14,20-pentaone. (Zortress 01)

Zortress Structural Formula Of Everolimus Is (1r, 9s, 12s, 15r, 16e, 18r, 19r, 21r, 23s, 24e, 26e, 28e, 30s, 32s, 35r)-1, 18-dihydroxy-12 -{(1r)-2-[(1s,3r,4r)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-1-methylethyl}-19,30-dimethoxy-15, 17, 21, 23, 29, 35-hexamethyl-11, 36-dioxa-4-aza-tricyclo[30.3.1.04,9] Hexatriaconta-16,24,26,28-tetraene-2, 3,10,14,20-pentaone. (Zortress 01)
FDA Label Image

Principal Display Panelpackage Label – 0.25 mgrx Only Ndc 0078-0417-20zortress® (everolimus) Tablets (Zortress 02)

Principal Display Panelpackage Label – 0.25 mgrx Only Ndc 0078-0417-20zortress® (everolimus) Tablets (Zortress 02)
This appears to be a product description for a medication called "& ZORTRESS (Everolimus) Tablets" in two different languages. The dosage is listed as 0.25mg per tablet and there is some information about the packaging. However, there is a lot of missing information and unclear formatting, making it difficult to understand the full context of the text.*
FDA Label Image

Principal Display Panelpackage Label – 0.5 mgrx Only Ndc 0078-0414-20zortress® (everolimus) Tablets (Zortress 03)

Principal Display Panelpackage Label – 0.5 mgrx Only Ndc 0078-0414-20zortress® (everolimus) Tablets (Zortress 03)
Wooomsastez Fonly (everolimus) Tablets are available in 0.5 mg per tablet strength.*
FDA Label Image

Principal Display Panelpackage Label – 0.75 mgrx Only Ndc 0078-0415-20zortress® (everolimus) Tablets (Zortress 04)

Principal Display Panelpackage Label – 0.75 mgrx Only Ndc 0078-0415-20zortress® (everolimus) Tablets (Zortress 04)
The text is related to a medication called Everolimus available in the form of tablets. No further information is available.*
FDA Label Image

Figure 1. Mean And 95% Ci Of Egfr (mdrd 4) [ml/min/1.73m2] By Visit Window And Treatment After Liver Transplantation (itt Population 24 Month Analysis)* (Zortress 05)

Figure 1. Mean And 95% Ci Of Egfr (mdrd 4) [ml/min/1.73m2] By Visit Window And Treatment After Liver Transplantation (itt Population 24 Month Analysis)* (Zortress 05)
This text provides information about a medical test result. The GFR (glomerular filtration rate) was measured using the MDRD 4 formula, and the result was 110 mL/min/1.73m^2. The remaining text indicates visit windows and treatment groups for a clinical trial, and is not relevant to the medical test result.*
FDA Label Image

Zortress 06

Zortress 06

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.